Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	16,5% cutaquig	-	-	-	-	1件: 65 💬
2	36-482-hyaluronoglucosaminidase ph20 (rhuph20)	Hyaluronidase	3件: D04455, D04456, D06604 💬	-	-	1件: 65 💬
3	[na]	-	-	-	-	7件:  6 , 11, 35, 46, 53, 65, 299 💬
4	A10bk03	-	-	-	-	1件: 65 💬
5	Abatacept	Abatacept	1件: D03203 💬	2件: CD80, CD86 💬	12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
6	Acoziborole (scyx-7158)	SCYX-7158	-	-	-	1件: 65 💬
7	Ada gene transfer	-	-	-	-	1件: 65 💬
8	Ada pbsc	-	-	-	-	1件: 65 💬
9	Ada umbilical cord blood cells	-	-	-	-	1件: 65 💬
10	Adagen	-	-	-	-	1件: 65 💬
11	Adenosine	Adenosine	1件: D00045 💬	4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬	12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	3件: 13, 58, 65 💬
12	Administration of drug (interferon-gamma 1-b) subcutaneously	-	-	-	-	1件: 65 💬
13	Adverse reactions of gammagard subcutaneously at week 12	-	-	-	-	1件: 65 💬
14	Adverse reactions of gammagard subcutaneously at week 24	-	-	-	-	1件: 65 💬
15	Adverse reactions of gammagard subcutaneously at week 36	-	-	-	-	1件: 65 💬
16	Adverse reactions of gammagard subdermally at week 12	-	-	-	-	1件: 65 💬
17	Adverse reactions of gammagard subdermally at week 24	-	-	-	-	1件: 65 💬
18	Adverse reactions of gammagard subdermally at week 36	-	-	-	-	1件: 65 💬
19	Aldesleukin	Aldesleukin	1件: D00748 💬	3件: IL2RA, IL2RB, IL2RG 💬	14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor	4件: 49, 65, 96, 97 💬
20	Alefacept	Alefacept	1件: D02800 💬	1件: CD58 💬	2件: Cell adhesion molecules, Epstein-Barr virus infection	6件: 37, 60, 65, 164, 284, 285 💬
21	Alemtuzumab	Alemtuzumab	1件: D02802 💬	-	-	16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬
22	Alemtuzumab 0.2 mg	Alemtuzumab	1件: D02802 💬	-	-	2件: 65, 164 💬
23	Alemtuzumab 0.3 mg	Alemtuzumab	1件: D02802 💬	-	-	2件: 65, 164 💬
24	Alentuzumab (campath)	-	-	-	-	1件: 65 💬
25	Allogeneic peripheral blood stem cell	-	-	-	-	1件: 65 💬
26	Anti-cd45	-	-	-	-	3件: 60, 65, 285 💬
27	Anti-thymocyte globulin	-	-	-	-	18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬
28	Anti-thymocyte globulin (rabbit)	Rabbit	-	-	-	4件: 60, 65, 96, 285 💬
29	Antithymocyte globulin	-	-	-	-	3件: 60, 65, 284 💬
30	Aproart	-	-	-	-	1件: 65 💬
31	Autologous cd34+ cell transduced with g2scid vector	-	-	-	-	1件: 65 💬
32	Autologous cd34+ cells transduced ex-vivo with the pcclchimgp91/vsvg lentiviral vector	-	-	-	-	1件: 65 💬
33	Autologous cd34+ cells transduced with the lentiviral vector containing the human wiskott aldrich sy	-	-	-	-	1件: 65 💬
34	Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with lentiviral vector that encodes for the human wiskott aldrich syndrome (was) cdna sequence	-	-	-	-	1件: 65 💬
35	Autologous cd34+ hscs transduced ex vivo with efs lentiviral vector encoding for the human ada gene	-	-	-	-	1件: 65 💬
36	Autologous cd34+cells transduced with the w1.6_hwasp_wpre (vsvg) lentiviral vector	-	-	-	-	1件: 65 💬
37	Autologous ex vivo gene therapy products based on the efs lv encoding for the human adenosine deaminase (ada) gene (efs-ada lv)	Adenosine	1件: D00045 💬	4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬	12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 65 💬
38	Azathioprine	Azathioprine	2件: D00238, D03033 💬	-	-	20件:  6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬
39	B-lymphocyte stimulator (blys)	-	-	-	-	1件: 65 💬
40	Bacteriophage	-	-	-	-	1件: 65 💬
41	Basiliximab	Basiliximab	1件: D03058 💬	1件: IL2RA 💬	11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	6件:  2 , 50, 65, 97, 222, 228 💬
42	Benznidazole	Benznidazole	1件: D02489 💬	-	-	1件: 65 💬
43	Biological sampling	-	-	-	-	1件: 65 💬
44	Bivigam	-	-	-	-	1件: 65 💬
45	Bms-188667	-	-	-	-	8件: 46, 49, 53, 65, 96, 97, 222, 271 💬
46	Bpx-501 t cells	-	-	-	-	4件: 65, 284, 285, 326 💬
47	Bt090	-	-	-	-	1件: 65 💬
48	Bt524	-	-	-	-	1件: 65 💬
49	Bt595	-	-	-	-	2件: 63, 65 💬
50	Bt681	-	-	-	-	1件: 65 💬
51	Busilvex	-	-	-	-	4件: 19, 36, 60, 65 💬
52	Busilvex - 6 mg/ml - concentrato per soluzione per infusione - uso endovenoso - flaconcino - 10 ml 8 flaconcini	-	-	-	-	2件: 19, 65 💬
53	Busulfan	Busulfan	1件: D00248 💬	-	-	13件: 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
54	Busulfan iv	Busulfan	1件: D00248 💬	-	-	1件: 65 💬
55	Busulfan test dose	Busulfan	1件: D00248 💬	-	-	1件: 65 💬
56	Busulfan, cyclophosphamide, atg, gcsf	Busulfan	3件: D00248, D00287, D07760 💬	-	-	2件: 65, 284 💬
57	Busulfan, fludarabine and atg	Busulfan	3件: D00248, D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	1件: 65 💬
58	Busulfan, fludarabine, atg, tli	Busulfan	3件: D00248, D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	2件: 65, 284 💬
59	C1 esterase inhibitor (human)	-	-	-	-	1件: 65 💬
60	C1 esterase inhibitor human	-	-	-	-	1件: 65 💬
61	C1 inhibitor	Human C1-esterase inhibitor	-	-	-	1件: 65 💬
62	C1 inhibitor concentrate	Human C1-esterase inhibitor	-	-	-	1件: 65 💬
63	C1-esterase inhibitor [recombinant] (c1-inh-r)	Human C1-esterase inhibitor	-	-	-	1件: 65 💬
64	C1-inh	Human C1-esterase inhibitor	-	-	-	1件: 65 💬
65	Campath	-	-	-	-	12件: 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬
66	Campath -1h	-	-	-	-	1件: 65 💬
67	Campath 1h	-	-	-	-	4件: 60, 65, 164, 285 💬
68	Campath, fludarabine, cyclophosphamide	Cyclophosphamide	4件: D00287, D01907, D07760, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	2件: 65, 284 💬
69	Cd3/cd19 neg allogeneic bmt	-	-	-	-	1件: 65 💬
70	Cd3/cd19 negative allogeneic hematopoietic stem cells	-	-	-	-	1件: 65 💬
71	Cd34 stem cell selection therapy	-	-	-	-	3件: 60, 65, 284 💬
72	Cd34+	-	-	-	-	1件: 65 💬
73	Cd34+ cells transduced with ada retrovir	-	-	-	-	1件: 65 💬
74	Cd34+ hscs transduced with the lentivirus vector, vsv-g pseudotyped cl20-4i-ef1a-h?c-opt	-	-	-	-	1件: 65 💬
75	Cd34+cells	-	-	-	-	2件: 65, 285 💬
76	Cd45ra-depleted dli	-	-	-	-	2件: 60, 65 💬
77	Cdz173	-	-	-	-	2件: 53, 65 💬
78	Chloride	Chloride ion	-	-	-	25件:  6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬
79	Cryopreserved efs-ada lv transduced patient cd34+ cells	-	-	-	-	1件: 65 💬
80	Cryopreserved g2scid lentiviral vector transduced patient cd34+ cells	-	-	-	-	1件: 65 💬
81	Cultured thymus tissue for implantation (ctti)	-	-	-	-	1件: 65 💬
82	Cultured thymus tissue implantation (ctti)	-	-	-	-	1件: 65 💬
83	Cutaquig	-	-	-	-	1件: 65 💬
84	Cuvitru	-	-	-	-	1件: 65 💬
85	Cuvitru 200 mg/ml solution for subcutaneous injection	-	-	-	-	1件: 65 💬
86	Cyclophosphamide	Cyclophosphamide	2件: D00287, D07760 💬	-	-	44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
87	Cyclophosphamide (cytoxan)	Cyclophosphamide	2件: D00287, D07760 💬	-	-	1件: 65 💬
88	Cyclophosphamide 30	Cyclophosphamide	2件: D00287, D07760 💬	-	-	3件: 65, 285, 326 💬
89	Cyclophosphamide 40	Cyclophosphamide	2件: D00287, D07760 💬	-	-	3件: 65, 285, 326 💬
90	Cyclophosphamide dose level 1	Cyclophosphamide	2件: D00287, D07760 💬	-	-	2件: 65, 284 💬
91	Cyclophosphamide dose level 2	Cyclophosphamide	2件: D00287, D07760 💬	-	-	2件: 65, 284 💬
92	Cyclophosphamide dose level 3	Cyclophosphamide	2件: D00287, D07760 💬	-	-	2件: 65, 284 💬
93	Cyclophosphamide dose level 4	Cyclophosphamide	2件: D00287, D07760 💬	-	-	2件: 65, 284 💬
94	Cyclophosphamide post transplant	Cyclophosphamide	2件: D00287, D07760 💬	-	-	1件: 65 💬
95	Cyclosporine	Cyclosporine	1件: D00184 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬
96	Cyclosporins	-	-	-	-	4件: 53, 60, 65, 222 💬
97	Daclizumab	Daclizumab	1件: D03639 💬	1件: IL2RA 💬	11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	7件: 13, 56, 60, 65, 97, 283, 284 💬
98	Danazol	Danazol	1件: D00289 💬	3件: AR, ESR1, PGR 💬	11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway	5件: 60, 63, 64, 65, 285 💬
99	Data collection	-	-	-	-	1件: 65 💬
100	Db289	-	-	-	-	1件: 65 💬
101	Depletion in cd45ra graft donor	-	-	-	-	1件: 65 💬
102	Device: cell processing for tcrabeta+/cd19+ depletion	-	-	-	-	1件: 65 💬
103	Device: cell processing for tcraß+/cd19+ depletion	-	-	-	-	1件: 65 💬
104	Device: chrono super pid then generic syringe-gammanorm	-	-	-	-	1件: 65 💬
105	Device: clinimacs	-	-	-	-	2件: 60, 65 💬
106	Device: clinimacs® cd34 reagent system cell sorter device	-	-	-	-	1件: 65 💬
107	Device: continuous glucose monitor	Dextrose, unspecified form	-	-	-	1件: 65 💬
108	Device: generic syringe then chrono super pid-gammanorm	-	-	-	-	1件: 65 💬
109	Device: isolex 300i magnetic cell selector	-	-	-	-	1件: 65 💬
110	Device: miltenyi clinimacs	-	-	-	-	2件: 62, 65 💬
111	Device: miltenyi clinimacs selection system	-	-	-	-	1件: 65 💬
112	Device: unrelated pbsc with t cell depletion	-	-	-	-	1件: 65 💬
113	Dexametasone fosfato sodico	-	-	-	-	1件: 65 💬
114	Dexamethasone	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
115	Dexamethasone 21-dihydrogen phosphate	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 65 💬
116	Dexamethasone sodium phosphate	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	3件: 65, 70, 96 💬
117	Dexamethasone sodium phosphate ph. eur.	Dexamethasone	9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 65 💬
118	Dextrose	Dextrose, unspecified form	-	-	-	4件: 56, 60, 65, 70 💬
119	Dextrose, 5% in water	Dextrose, unspecified form	1件: D00001 💬	-	-	1件: 65 💬
120	Diagnostic test: blood drawing in healthy controls	-	-	-	-	1件: 65 💬
121	Diagnostic test: blood drawing in patients with was	-	-	-	-	1件: 65 💬
122	Diagnostic test: functional and antigenic c1 inhibitor	Human C1-esterase inhibitor	-	-	-	1件: 65 💬
123	Diagnostic test: oral glucose tolerance test	Dextrose, unspecified form	-	-	-	3件: 13, 65, 299 💬
124	Diagnostic test: rna and neopterin detection	Neopterin	-	-	-	1件: 65 💬
125	Donor peripheral blood stem cells.	-	-	-	-	1件: 65 💬
126	Ef1as-ada lentiviral vector gene modified autologous cd34+ cells	-	-	-	-	1件: 65 💬
127	Ef1as-ada lentiviral vector transduced patient cd34+ cells	-	-	-	-	1件: 65 💬
128	Efficacy of gammagard subcutaneously at week 12	-	-	-	-	1件: 65 💬
129	Efficacy of gammagard subcutaneously at week 24	-	-	-	-	1件: 65 💬
130	Efficacy of gammagard subcutaneously at week 36	-	-	-	-	1件: 65 💬
131	Efficacy of gammagard subdermally at week 12	-	-	-	-	1件: 65 💬
132	Efficacy of gammagard subdermally at week 24	-	-	-	-	1件: 65 💬
133	Efficacy of gammagard subdermally at week 36	-	-	-	-	1件: 65 💬
134	Eflornithine	Eflornithine	1件: D07883 💬	1件: ODC1 💬	3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways	1件: 65 💬
135	Eflornithine plus nifurtimox combination therapy	Eflornithine	2件: D00833, D07883 💬	1件: ODC1 💬	3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways	1件: 65 💬
136	Elapegademase	Elapegademase	1件: D11017 💬	1件: ADA 💬	3件: Metabolic pathways, Primary immunodeficiency, Purine metabolism	1件: 65 💬
137	Elapegademase-lvlr	Elapegademase	1件: D11017 💬	1件: ADA 💬	3件: Metabolic pathways, Primary immunodeficiency, Purine metabolism	1件: 65 💬
138	Eltrombopag	Eltrombopag	1件: D03978 💬	-	-	5件: 60, 63, 65, 284, 285 💬
139	Empagliflozin	Empagliflozin	1件: D10459 💬	-	-	3件: 65, 72, 257 💬
140	Ep2006	-	-	-	-	1件: 65 💬
141	Ep2006 (filgrastim)	Filgrastim	1件: D03235 💬	1件: CSF3R 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	1件: 65 💬
142	Etoposide	Etoposide	2件: D00125, D04107 💬	2件: TOP2A, TOP2B 💬	1件: Platinum drug resistance	11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
143	Ex vivo culture and transduction of the patient's autologous cd34+ hsc with lentivirus vector vsv-g pseudotyped cl20- 4i-ef1a-hyc-opt vector	-	-	-	-	1件: 65 💬
144	Ezn-2279	-	-	-	-	1件: 65 💬
145	Fansidar (pyrimethamine and sulfadoxine)	Pyrimethamine	2件: D00488, D00580 💬	-	-	1件: 65 💬
146	Fexinidazole	Fexinidazole	1件: D11252 💬	-	-	1件: 65 💬
147	Fibrinogen	Fibrinogen human	-	-	-	3件: 14, 65, 288 💬
148	Fibrinogen (coagulation factori)	Fibrinogen human	-	-	-	1件: 65 💬
149	Fibrinogen concentrate from human plasma	Fibrinogen human	-	-	-	1件: 65 💬
150	Filgrastim	Filgrastim	1件: D03235 💬	1件: CSF3R 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	27件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
151	Filgrastim hexal	Filgrastim	1件: D03235 💬	1件: CSF3R 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	1件: 65 💬
152	Filgrastim, alemtuzumab	Alemtuzumab	2件: D02802, D03235 💬	1件: CSF3R 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	1件: 65 💬
153	Flebogamma 5% dif	-	-	-	-	1件: 65 💬
154	Fludarabina	Fludarabine	2件: D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	2件: 19, 65 💬
155	Fludarabina accord	Fludarabine	2件: D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	1件: 65 💬
156	Fludarabina teva - 25 mg/ml concentrato per soluzione iniettabile o per infusione 1 flaconcino di vetro da 2 ml	Fludarabine	2件: D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	1件: 65 💬
157	Fludarabine	Fludarabine	2件: D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬
158	Fludarabine monophosphate	Fludarabine	2件: D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	3件: 65, 284, 326 💬
159	Fludarabine phosphate	Fludarabine	2件: D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	11件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬
160	Fludarabine phosphate 30 mg	Fludarabine	2件: D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	2件: 65, 164 💬
161	Fludarabine phosphate 40 mg	Fludarabine	2件: D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	2件: 65, 164 💬
162	Fludarabine, busulfan, thymoglobulin	Antithymocyte immunoglobulin (rabbit)	3件: D00248, D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	1件: 65 💬
163	Fludarabine, melphalan, thiotepa	Fludarabine	4件: D00369, D00583, D01907, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	1件: 65 💬
164	Fortecortin	-	-	-	-	2件: 28, 65 💬
165	Fortecortin inject 40 mg amp.	-	-	-	-	1件: 65 💬
166	Fucose	Fucose	-	-	-	1件: 65 💬
167	G-csf	Filgrastim	1件: D03235 💬	1件: CSF3R 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	16件:  2 ,  6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬
168	G-csf for conditioning before hsct.	Filgrastim	1件: D03235 💬	1件: CSF3R 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	1件: 65 💬
169	G1xcg	-	-	-	-	1件: 65 💬
170	G1xcgd transduced cd34+ cells	-	-	-	-	1件: 65 💬
171	Gadolinium	Gadolinium	-	-	-	6件: 13, 34, 46, 58, 65, 86 💬
172	Gadolinium for abdomen	Gadolinium	-	-	-	1件: 65 💬
173	Gadolinium for lower back	Gadolinium	-	-	-	1件: 65 💬
174	Gammagard liquid	-	-	-	-	1件: 65 💬
175	Gammagard s/d (solvent/detergent)	-	-	-	-	1件: 65 💬
176	Gammaglobulin	-	-	-	-	1件: 65 💬
177	Gammanorm	-	-	-	-	2件: 14, 65 💬
178	Gammanorm 165 mg/ml	-	-	-	-	1件: 65 💬
179	Gammaplex	-	-	-	-	2件: 63, 65 💬
180	Gammaplex (5%)	-	-	-	-	1件: 65 💬
181	Gammaplex (intravenous immunoglobulin)	-	-	-	-	1件: 65 💬
182	Gammaplex 10	-	-	-	-	1件: 65 💬
183	Gamunex-c	-	-	-	-	1件: 65 💬
184	Gcsf	-	-	-	-	1件: 65 💬
185	Gene therapy method for cgd	-	-	-	-	1件: 65 💬
186	Gene transfer	-	-	-	-	1件: 65 💬
187	Gene-transduced autologous cd34+ stem cells	-	-	-	-	1件: 65 💬
188	Genetic: cl20-i4-ef1a-h?c-opt	-	-	-	-	1件: 65 💬
189	Genetic: infusion of autologous cryopreserved efs-ada lv cd34+ cells (otl-101)	-	-	-	-	1件: 65 💬
190	Genetic: infusion of autologous efs-ada lv cd34+ (otl-101)	-	-	-	-	1件: 65 💬
191	Genetic: infusion of autologous efs-ada lv cd34+ cells	-	-	-	-	1件: 65 💬
192	Genetically modified autologous blood stem cells	-	-	-	-	1件: 65 💬
193	Glucose	Dextrose, unspecified form	-	-	-	15件:  2 ,  6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬
194	Glycolic acid	Glycolic acid	-	-	-	1件: 65 💬
195	Glycosade	-	-	-	-	3件: 65, 256, 257 💬
196	Gold	Gold	-	-	-	38件:  2 ,  5 ,  6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬
197	Granulocyte colony stimulating factor	Filgrastim	1件: D03235 💬	1件: CSF3R 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	6件:  2 , 28, 36, 57, 65, 85 💬
198	Granulocyte colony stimulating factor (g-csf)	Filgrastim	1件: D03235 💬	1件: CSF3R 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	1件: 65 💬
199	Gtg003.08	-	-	-	-	1件: 65 💬
200	Gvhd prophylaxis	-	-	-	-	2件: 60, 65 💬
201	Haemocomplettan p	-	-	-	-	1件: 65 💬
202	Haemocomplettan(r) p	-	-	-	-	1件: 65 💬
203	Haemocomplettan(r) p 1g/2g	-	-	-	-	1件: 65 💬
204	Haplo bm with t cell depletion	-	-	-	-	1件: 65 💬
205	Haploidentical hematopoietic cell transplantation	-	-	-	-	2件: 60, 65 💬
206	Hematopoetic stem cell transplantation	-	-	-	-	5件: 19, 65, 120, 160, 326 💬
207	Hematopoietic stem cell transplant	-	-	-	-	1件: 65 💬
208	Hizentra	-	-	-	-	4件: 14, 50, 51, 65 💬
209	Hizentra®	-	-	-	-	2件: 14, 65 💬
210	Horse -anti-thymocyte	-	-	-	-	1件: 65 💬
211	Hpc, a infusion	-	-	-	-	2件: 60, 65 💬
212	Htlp	-	-	-	-	1件: 65 💬
213	Human fibrinogen	Fibrinogen human	-	-	-	1件: 65 💬
214	Human fibrinogen concentrate	Fibrinogen human	-	-	-	1件: 65 💬
215	Human immunglobulin g (igg)	-	-	-	-	1件: 65 💬
216	Human immunoglobulin	-	-	-	-	2件: 63, 65 💬
217	Human immunoglobulin g	Human immunoglobulin G	-	-	-	4件: 14, 50, 63, 65 💬
218	Human normal immunoglobulin	Human immunoglobulin G	-	-	-	9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬
219	Human normal immunoglobulin (iv)	Human immunoglobulin G	-	-	-	4件: 11, 14, 63, 65 💬
220	Human normal immunoglobulin (ivig)	Human immunoglobulin G	-	-	-	2件: 50, 65 💬
221	Human normal immunoglobulin (subcutaneous - intramuscular immunoglobulin)	Human immunoglobulin G	-	-	-	1件: 65 💬
222	Human normal immunoglobulin (subcutaneous)	Human immunoglobulin G	-	-	-	1件: 65 💬
223	Human normal immunoglobulin for	Human immunoglobulin G	-	-	-	1件: 65 💬
224	Human normal immunoglobulin for intravenous administration	Human immunoglobulin G	-	-	-	3件: 14, 51, 65 💬
225	Human normal immunoglobulin for intravenous use	Human immunoglobulin G	-	-	-	2件: 63, 65 💬
226	Human normal immunoglobulin for intravenous use (ivig)	Human immunoglobulin G	-	-	-	1件: 65 💬
227	Human normal immunoglobulin for subcutaneous administration	Human immunoglobulin G	-	-	-	2件: 51, 65 💬
228	Human normal immunoglobulin for subcutaneous administration (igsc)	Human immunoglobulin G	-	-	-	1件: 65 💬
229	Human normal immunoglobulin g (igg > 98% purity)	Human immunoglobulin G	-	-	-	3件: 14, 63, 65 💬
230	Hyaluronidase	Hyaluronidase	3件: D04455, D04456, D06604 💬	-	-	4件: 28, 51, 65, 331 💬
231	Hyaluronoglucosaminidase	Hyaluronidase	3件: D04455, D04456, D06604 💬	-	-	1件: 65 💬
232	Hydroxyurea	Hydroxyurea	1件: D00341 💬	1件: RRM2 💬	6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway	8件:  3 , 13, 19, 20, 65, 85, 86, 284 💬
233	Hyqvia	-	-	-	-	2件: 14, 65 💬
234	Hyqvia 100 mg/ml solution for infusion for subcutaneous use	-	-	-	-	1件: 65 💬
235	I10e	-	-	-	-	3件: 14, 63, 65 💬
236	Ibuprofen	Ibuprofen	4件: D00126, D01122, D04490, D06606 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	6件: 13, 46, 65, 113, 271, 299 💬
237	Ifn-gamma	-	-	-	-	1件: 65 💬
238	Ig vena 50 g/l solution for infusion 100 ml vial + infusion set	-	-	-	-	2件: 63, 65 💬
239	Igg next generation	-	-	-	-	2件: 63, 65 💬
240	Ighy10	-	-	-	-	1件: 65 💬
241	Igiv, 10%	-	-	-	-	2件: 14, 65 💬
242	Igiv-c 10%	-	-	-	-	1件: 65 💬
243	Ignextgen 16%	-	-	-	-	1件: 65 💬
244	Igng	-	-	-	-	1件: 65 💬
245	Igpro10	-	-	-	-	3件: 14, 51, 65 💬
246	Igpro20	-	-	-	-	4件: 14, 50, 51, 65 💬
247	Igsc 20%	-	-	-	-	1件: 65 💬
248	Igsc 20% 150 mg/kg	-	-	-	-	1件: 65 💬
249	Igsc 20% daily push versus 2 times per week pump	-	-	-	-	1件: 65 💬
250	Igsc 20% daily push versus every 2 weeks pump	-	-	-	-	1件: 65 💬
251	Igsc 20% daily push versus once a week pump	-	-	-	-	1件: 65 💬
252	Igsc, 16%	-	-	-	-	1件: 65 💬
253	Igsc, 20%	-	-	-	-	1件: 65 💬
254	Immune globulin infusion (human), 10%	-	-	-	-	1件: 65 💬
255	Immune globulin intravenous	-	-	-	-	1件: 65 💬
256	Immune globulin intravenous (human)	-	-	-	-	1件: 65 💬
257	Immune globulin intravenous (human) 5% liquid, ivig-sn™	-	-	-	-	1件: 65 💬
258	Immune globulin intravenous (human), 10%	-	-	-	-	2件: 14, 65 💬
259	Immune globulin intravenous (human), 10% solution	-	-	-	-	1件: 65 💬
260	Immune globulin intravenous (human), 10% tvr (triple virally reduced) solution	-	-	-	-	1件: 65 💬
261	Immune globulin intravenous (igiv)	-	-	-	-	1件: 65 💬
262	Immune globulin intravenous [human], 10% caprylate/chromatography purified	-	-	-	-	1件: 65 💬
263	Immune globulin subcutaneos, 20%	-	-	-	-	1件: 65 💬
264	Immune globulin subcutaneous (human)	-	-	-	-	2件: 14, 65 💬
265	Immune globulin subcutaneous (human) (scig)	-	-	-	-	1件: 65 💬
266	Immune globulin subcutaneous (human), 20%	-	-	-	-	1件: 65 💬
267	Immune globulin subcutaneous (human), 20% caprylate/chromatography purified (igsc 20%)	-	-	-	-	1件: 65 💬
268	Immune globulin subcutaneous (human), 20% solution	-	-	-	-	1件: 65 💬
269	Immune globulin subcutaneous (human), 20%, caprylate/chromatography purified	-	-	-	-	1件: 65 💬
270	Immune globulin subcutaneous, 20%	-	-	-	-	1件: 65 💬
271	Immune globulin subcutaneous, 20% solution (igsc, 20%)	-	-	-	-	1件: 65 💬
272	Immunglobulin (human)	-	-	-	-	1件: 65 💬
273	Immunoglobulin g	-	-	-	-	7件: 11, 13, 14, 49, 50, 63, 65 💬
274	Immunoglobulin g (ig nextgen 16%)	-	-	-	-	1件: 65 💬
275	Immunoglobulin intravenous (human)	-	-	-	-	1件: 65 💬
276	Immunoglobulins intravenous (human)	-	-	-	-	1件: 65 💬
277	Immunoglobulins, normal human	-	-	-	-	1件: 65 💬
278	Immunological diagnosis tests	-	-	-	-	1件: 65 💬
279	Immunosuppression only conditioning (ioc)	-	-	-	-	1件: 65 💬
280	Immunosuppression only conditioning - closed with amendment l	-	-	-	-	1件: 65 💬
281	Increlex	-	-	-	-	4件: 65, 78, 96, 299 💬
282	Infliximab	Infliximab	1件: D02598 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬
283	Inh	-	-	-	-	1件: 65 💬
284	Interferon gamma	Interferon Gamma	-	-	-	8件: 18, 65, 85, 107, 228, 299, 301, 326 💬
285	Interferon gamma-1b	Interferon Gamma	1件: D00747 💬	2件: IFNGR1, IFNGR2 💬	18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis	7件: 18, 65, 85, 228, 299, 301, 326 💬
286	Interferon-gamma	-	-	-	-	1件: 65 💬
287	Interleukin-2	Human interleukin-2	-	-	-	8件:  2 , 35, 49, 55, 65, 96, 97, 162 💬
288	Intratect	-	-	-	-	3件: 13, 35, 65 💬
289	Intravenous immunoglobulin infusion	-	-	-	-	1件: 65 💬
290	Intravenous infusion of transduced cells	-	-	-	-	1件: 65 💬
291	Itraconazole	Itraconazole	1件: D00350 💬	-	-	4件:  3 , 65, 227, 299 💬
292	Iv treatment with igsc, 10%	-	-	-	-	1件: 65 💬
293	Ivig	Human immunoglobulin G	-	-	-	8件: 11, 13, 14, 17, 35, 50, 51, 65 💬
294	Ivig-peg	-	-	-	-	1件: 65 💬
295	Jardiance	-	-	-	-	1件: 65 💬
296	Kedrion ivig 10%	-	-	-	-	1件: 65 💬
297	Kig10	-	-	-	-	1件: 65 💬
298	Kineret	-	-	-	-	9件: 28, 41, 46, 49, 65, 106, 107, 266, 299 💬
299	Kiovig	-	-	-	-	2件: 14, 65 💬
300	Kiovig 100 mg/ml solution for infusion	-	-	-	-	2件: 14, 65 💬
301	Klh	-	-	-	-	2件: 13, 65 💬
302	Kvd900	-	-	-	-	1件: 65 💬
303	Kvd900 100 mg film coated tablet	-	-	-	-	1件: 65 💬
304	L-fucose	Fucose	-	-	-	1件: 65 💬
305	Ladicell	-	-	-	-	1件: 65 💬
306	Ldt	-	-	-	-	1件: 65 💬
307	Lemtrada	-	-	-	-	2件: 13, 65 💬
308	Leniolisib	Leniolisib	1件: D11158 💬	3件: PIK3CA, PIK3CB, PIK3CD 💬	103件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway	2件: 53, 65 💬
309	Lenograstim	Lenograstim	1件: D03247 💬	1件: CSF3R 💬	5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	7件:  2 , 13, 16, 18, 19, 57, 65 💬
310	Lentiviral g1xcgd gene therapy	-	-	-	-	1件: 65 💬
311	Lentiviral vector transduced cd34+ cells	-	-	-	-	1件: 65 💬
312	Lfb-igsc	-	-	-	-	1件: 65 💬
313	Mabthera	-	-	-	-	22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬
314	Mabthera - 2 fiale 100 mg 10 ml	-	-	-	-	2件: 19, 65 💬
315	Mavorixafor	-	-	-	-	1件: 65 💬
316	Mctls	-	-	-	-	1件: 65 💬
317	Melarsoprol	Melarsoprol	1件: D00832 💬	-	-	1件: 65 💬
318	Melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d	Eflornithine	2件: D00832, D07883 💬	1件: ODC1 💬	3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways	1件: 65 💬
319	Melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d	Melarsoprol	2件: D00832, D00833 💬	-	-	1件: 65 💬
320	Melphalan	Melphalan	1件: D00369 💬	-	-	15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬
321	Mesna	-	-	-	-	11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
322	Methotrexate	Methotrexate	2件: D00142, D02115 💬	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
323	Methylprednisolone	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
324	Methylprednisolone or prednisolone	Methylprednisolone	14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 65 💬
325	Mmf	-	-	-	-	13件: 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬
326	Monitor	Methamidophos	-	-	-	18件:  2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬
327	Mozobil	-	-	-	-	3件: 19, 65, 285 💬
328	Mozobil - 20 mg/ml - soluzione iniettabile - uso sottocutaneo - flaconcino (vetro) - 24 mg/1.2 ml 1 flaconcino	-	-	-	-	1件: 65 💬
329	Mozobil 20mg/ml vial (injectable solution for subcutaneous use)	-	-	-	-	1件: 65 💬
330	Mozobil 20mg/ml vial (injectable solution, subcutaneous use)	-	-	-	-	1件: 65 💬
331	Mozobil,	-	-	-	-	1件: 65 💬
332	Mycophenolate	Mycophenolic acid	1件: D05096 💬	2件: IMPDH1, IMPDH2 💬	3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism	34件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
333	Mycophenolate mofetil	Mycophenolate mofetil	4件: D00752, D05094, D05095, D05096 💬	2件: IMPDH1, IMPDH2 💬	3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism	32件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
334	Mycophenolate mofetil (mmf)	Mycophenolate mofetil	4件: D00752, D05094, D05095, D05096 💬	2件: IMPDH1, IMPDH2 💬	3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism	7件: 13, 49, 51, 60, 65, 66, 222 💬
335	Myeloablative conditioning-closed with amendment l	-	-	-	-	1件: 65 💬
336	Myeloablative preparative regimen	-	-	-	-	3件: 62, 65, 284 💬
337	Myelostim	-	-	-	-	1件: 65 💬
338	Myelostim - 34 1 flaconcino liofilizzato 33.6 miu + siringa preriempita solvente 1 ml	-	-	-	-	2件: 19, 65 💬
339	Myelostim 34 milions ui/ml - powder and solvent for solution for injection/infusion	-	-	-	-	1件: 65 💬
340	Myelostim 34 milions ui/ml, powder and solvent for solution for injection or infusion	-	-	-	-	1件: 65 💬
341	Nanogam 100 mg/ml	-	-	-	-	1件: 65 💬
342	Nanogam® 50 mg/ml	-	-	-	-	1件: 65 💬
343	Ndv-3a	-	-	-	-	1件: 65 💬
344	Neopterin	Neopterin	-	-	-	1件: 65 💬
345	Newgam	-	-	-	-	3件: 14, 63, 65 💬
346	Newnorm	-	-	-	-	1件: 65 💬
347	Nifurtimox	Nifurtimox	1件: D00833 💬	-	-	1件: 65 💬
348	Nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d	Eflornithine	2件: D00833, D07883 💬	1件: ODC1 💬	3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways	1件: 65 💬
349	Nifurtimox-eflronithine combination treatment (nect)	Nifurtimox	1件: D00833 💬	-	-	1件: 65 💬
350	None	-	-	-	-	14件: 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬
351	Normal human immunoglobulin g	Human immunoglobulin G	-	-	-	1件: 65 💬
352	Noxafil	-	-	-	-	3件: 60, 65, 299 💬
353	Noxafil 40 mg/ml oral solution	-	-	-	-	1件: 65 💬
354	Octa-c1-inh	Human C1-esterase inhibitor	-	-	-	1件: 65 💬
355	Octagam	-	-	-	-	2件: 13, 65 💬
356	Octagam 10%	-	-	-	-	3件: 50, 63, 65 💬
357	Octagam 5%	-	-	-	-	2件: 13, 65 💬
358	Octagam 50 mg/ml oldatos infúzió	-	-	-	-	1件: 65 💬
359	Octanorm	-	-	-	-	2件: 50, 65 💬
360	Octanorm 16.5%	-	-	-	-	2件: 50, 65 💬
361	Omalizumab	Omalizumab	1件: D05251 💬	1件: FCER1A 💬	4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway	7件: 46, 53, 65, 98, 162, 226, 299 💬
362	Omalizumab (xolair)	Omalizumab	1件: D05251 💬	1件: FCER1A 💬	4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway	1件: 65 💬
363	Orencia	-	-	-	-	13件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬
364	Orencia® 125 mg solution for injection in pre-filled syringe	-	-	-	-	1件: 65 💬
365	Other hematological agents	-	-	-	-	1件: 65 💬
366	Other:	-	-	-	-	2件:  2 , 65 💬
367	Other: 0.9% sodium chloride	Chloride ion	1件: D02056 💬	-	-	1件: 65 💬
368	Other: blood sampling for laboratory developed test (ldt) analysis	-	-	-	-	1件: 65 💬
369	Other: cultured thymus tissue implantation and parental parathyroid transplantation	-	-	-	-	1件: 65 💬
370	Other: cultured thymus tissue implantation with parathyroid transplantation	-	-	-	-	1件: 65 💬
371	Other: donor lymphocyte infusion	-	-	-	-	1件: 65 💬
372	Other: food diary	-	-	-	-	1件: 65 💬
373	Other: haematopoietic stem cell transplantation (hsct)	-	-	-	-	1件: 65 💬
374	Other: laboratory biomarker analysis	-	-	-	-	21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬
375	Other: medical history questionnaires	-	-	-	-	1件: 65 💬
376	Other: modified mixed meal tolerance test	-	-	-	-	1件: 65 💬
377	Other: modified oral glucose tolerance test	Dextrose, unspecified form	-	-	-	1件: 65 💬
378	Other: palliative care	-	-	-	-	5件: 19, 65, 120, 160, 326 💬
379	Otl-101	-	-	-	-	1件: 65 💬
380	Otl-103	-	-	-	-	1件: 65 💬
381	Otl-103 dispersion for infusion	-	-	-	-	1件: 65 💬
382	Ovastat	Treosulfan	1件: D07253 💬	-	-	2件: 13, 65 💬
383	Ovastat 1000	Treosulfan	1件: D07253 💬	-	-	2件: 13, 65 💬
384	Ovastat 1000 (treosulfan injection)	Treosulfan	1件: D07253 💬	-	-	1件: 65 💬
385	Ovastat 1000 mg, powder for solution for infusion	Treosulfan	1件: D07253 💬	-	-	1件: 65 💬
386	Ovastat 5000	Treosulfan	1件: D07253 💬	-	-	2件: 13, 65 💬
387	Ovastat 5000 (treosulfan injection)	Treosulfan	1件: D07253 💬	-	-	1件: 65 💬
388	Ovastat 5000 mg, powder for solution for infusion	Treosulfan	1件: D07253 💬	-	-	1件: 65 💬
389	Palifermin	Palifermin	1件: D05338 💬	1件: FGFR2 💬	13件: Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells	4件: 13, 38, 39, 65 💬
390	Pantoprazole	Pantoprazole	2件: D02593, D05353 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	2件: 13, 65 💬
391	Pantoprazolo 20 mg gastro-resistant tablets	-	-	-	-	1件: 65 💬
392	Peg	-	-	-	-	9件:  6 , 13, 46, 65, 78, 96, 97, 240, 299 💬
393	Peg-ada	-	-	-	-	1件: 65 💬
394	Peg-ada ert	-	-	-	-	1件: 65 💬
395	Peg-interleukin-2	Human interleukin-2	-	-	-	1件: 65 💬
396	Pentamidine	Pentamidine	2件: D00834, D08333 💬	-	-	1件: 65 💬
397	Peripheral blood stem cells	-	-	-	-	2件: 51, 65 💬
398	Pha-022121	-	-	-	-	1件: 65 💬
399	Phagocyte oxidase subunit transduced cd34 hematopoietic stem cells	-	-	-	-	1件: 65 💬
400	Phosphate	Phosphate ion	-	-	-	30件:  2 ,  3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬
401	Pid	-	-	-	-	1件: 65 💬
402	Pioglitazone	Pioglitazone	2件: D00945, D08378 💬	1件: PPARG 💬	9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer	17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
403	Plerixafor	Plerixafor	1件: D08971 💬	1件: CXCR4 💬	12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor	5件: 20, 51, 65, 285, 299 💬
404	Plerixafor for conditioning before hsct.	Plerixafor	1件: D08971 💬	1件: CXCR4 💬	12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor	1件: 65 💬
405	Pncj pps	-	-	-	-	1件: 65 💬
406	Pneumo 23	-	-	-	-	1件: 65 💬
407	Polyclonal igg	-	-	-	-	1件: 65 💬
408	Posaconazole	Posaconazole	1件: D02555 💬	-	-	3件: 60, 65, 299 💬
409	Posaconazole (psz)	Posaconazole	1件: D02555 💬	-	-	1件: 65 💬
410	Pps	-	-	-	-	1件: 65 💬
411	Prednisolone	Prednisolone	8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
412	Prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	47件:  2 ,  6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
413	Prevenar	-	-	-	-	1件: 65 💬
414	Privigen	-	-	-	-	4件: 11, 14, 51, 65 💬
415	Privigen®	-	-	-	-	3件: 14, 63, 65 💬
416	Procedure: allo bmt	-	-	-	-	1件: 65 💬
417	Procedure: allogeneic bone marrow transplantation	-	-	-	-	6件: 60, 65, 96, 164, 284, 285 💬
418	Procedure: allogeneic hematopoietic stem cell transplantation	-	-	-	-	8件: 28, 51, 60, 62, 65, 164, 284, 285 💬
419	Procedure: allogeneic hsc	-	-	-	-	1件: 65 💬
420	Procedure: allogeneic hsct	-	-	-	-	1件: 65 💬
421	Procedure: blood draw	-	-	-	-	5件:  6 , 19, 65, 231, 299 💬
422	Procedure: blood sample	-	-	-	-	1件: 65 💬
423	Procedure: ct scan	-	-	-	-	1件: 65 💬
424	Procedure: cyclophosphamide	Cyclophosphamide	2件: D00287, D07760 💬	-	-	1件: 65 💬
425	Procedure: hematopoietic stem cell transplantation	-	-	-	-	3件: 13, 65, 285 💬
426	Procedure: in vitro-treated peripheral blood stem cell transplantation	-	-	-	-	2件: 60, 65 💬
427	Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation	-	-	-	-	6件: 28, 51, 60, 62, 65, 285 💬
428	Procedure: peripheral blood stem cell transplantation	-	-	-	-	11件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬
429	Procedure: stem cell infusion	-	-	-	-	5件: 28, 60, 65, 284, 285 💬
430	Procedure: stem cell transplant	-	-	-	-	5件: 19, 20, 65, 164, 284 💬
431	Procedure: stem cell transplantation	-	-	-	-	6件: 19, 51, 60, 62, 65, 326 💬
432	Procedure: total body irradiation	-	-	-	-	6件: 19, 20, 51, 60, 65, 285 💬
433	Procedure: total lymphoid irradiation	-	-	-	-	3件: 65, 284, 326 💬
434	Procedure: umbilical cord blood transplantation	-	-	-	-	5件: 60, 65, 284, 285, 326 💬
435	Proleukin	-	-	-	-	3件:  2 , 49, 65 💬
436	Proleukin® s	-	-	-	-	1件: 65 💬
437	Promacta	-	-	-	-	2件: 63, 65 💬
438	Prometic's immune globulin intravenous 10%	-	-	-	-	1件: 65 💬
439	Psrs11.efs.il2rg.pre* retroviral vector	-	-	-	-	1件: 65 💬
440	Psrs11.efs.il2rg.pre* retroviral vector transduce	-	-	-	-	1件: 65 💬
441	Psrs11.efs.il2rg.pre* retroviral vector transduced cells	-	-	-	-	1件: 65 💬
442	Pth	-	-	-	-	2件: 65, 235 💬
443	Pth 1-34	Teriparatide	1件: D06078 💬	1件: PTH1R 💬	3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action	2件: 65, 235 💬
444	Purified vero cell vaccine)	-	-	-	-	1件: 65 💬
445	Pyrimethamine	Pyrimethamine	1件: D00488 💬	-	-	4件:  2 ,  4 , 19, 65 💬
446	R-hil-18bp	-	-	-	-	1件: 65 💬
447	Rabbit	Rabbit	-	-	-	8件: 11, 13, 49, 51, 60, 65, 96, 285 💬
448	Rabbit anti-thymocyte globulin	Rabbit	-	-	-	2件: 49, 65 💬
449	Radiation: radiation therapy	-	-	-	-	5件: 34, 60, 65, 284, 285 💬
450	Radiation: total body 200cgy	-	-	-	-	1件: 65 💬
451	Radiation: total body irradiation	-	-	-	-	7件: 36, 49, 51, 60, 65, 283, 284 💬
452	Radiation: total body irradiation (tbi)	-	-	-	-	3件: 60, 65, 285 💬
453	Radiation: total lymphoid irradiation (tli)	-	-	-	-	2件: 60, 65 💬
454	Radiation: total-body irradiation	-	-	-	-	9件: 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
455	Rag1 lv cd34+ cells	-	-	-	-	1件: 65 💬
456	Ranitidine	Ranitidine	2件: D00422, D00673 💬	1件: HRH2 💬	3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction	2件: 13, 65 💬
457	Recombinant human hyaluronidase	Hyaluronidase	3件: D04455, D04456, D06604 💬	-	-	2件: 28, 65 💬
458	Recombinant human hyaluronidase (rhuph20)	Hyaluronidase	3件: D04455, D04456, D06604 💬	-	-	1件: 65 💬
459	Recombinant human hyaluronidase (rhuph20)+ immune globulin intravenous (igiv)	Hyaluronidase	3件: D04455, D04456, D06604 💬	-	-	1件: 65 💬
460	Recombinant human hyaluronidase + immune globulin intravenous	Hyaluronidase	3件: D04455, D04456, D06604 💬	-	-	1件: 65 💬
461	Reduced intensity conditioning	-	-	-	-	2件: 19, 65 💬
462	Reduced intensity conditioning (ric)	-	-	-	-	1件: 65 💬
463	Reduced intensity preparative regimen	-	-	-	-	3件: 62, 65, 284 💬
464	Reduced toxicity ablative regimen	-	-	-	-	3件: 62, 65, 284 💬
465	Retroviral sf71-gp91phox transduced cd34+ cells	-	-	-	-	1件: 65 💬
466	Retrovirus-mediated gene transfer	-	-	-	-	1件: 65 💬
467	Rhucd40l	-	-	-	-	1件: 65 💬
468	Ri-002	-	-	-	-	1件: 65 💬
469	Rifaximin	Rifaximin	1件: D02554 💬	-	-	6件:  6 , 65, 96, 97, 99, 296 💬
470	Rimiducid	Rimiducid	1件: D11195 💬	1件: CASP9 💬	34件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway	6件: 19, 60, 65, 284, 285, 326 💬
471	Rituximab	Rituximab	1件: D02994 💬	1件: MS4A1 💬	1件: Hematopoietic cell lineage	47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
472	Rituximab (rtx) and azathioprine (aza)	Azathioprine	3件: D00238, D02994, D03033 💬	1件: MS4A1 💬	1件: Hematopoietic cell lineage	1件: 65 💬
473	Rivogenlecleucel	-	-	-	-	6件: 19, 60, 65, 284, 285, 326 💬
474	Romiplostim	Romiplostim	1件: D08990 💬	1件: MPL 💬	2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway	4件: 60, 63, 64, 65 💬
475	Rp-l201	-	-	-	-	1件: 65 💬
476	Rtx	-	-	-	-	4件: 11, 65, 222, 240 💬
477	Sc treatment with igsc, 10% with rhuph20 followed by iv/igsc, 10% only (safety)	-	-	-	-	1件: 65 💬
478	Sc treatment with igsc, 10% with rhuph20 followed by sc/igsc, 10% only (safety)	-	-	-	-	1件: 65 💬
479	Scid screening	-	-	-	-	1件: 65 💬
480	Scyx-7158	SCYX-7158	-	-	-	1件: 65 💬
481	Sirolimus	Sirolimus	1件: D00753 💬	1件: MTOR 💬	50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway	35件:  6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬
482	Sodium chloride	Chloride ion	1件: D02056 💬	-	-	20件:  6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬
483	Somatic gene-therapy by x-cgd	-	-	-	-	1件: 65 💬
484	Sta-5326	-	-	-	-	2件: 65, 96 💬
485	Stelara (ustekinumab)	Ustekinumab	1件: D09214 💬	3件: IL12A, IL12B, IL23A 💬	26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus	1件: 65 💬
486	Stem cell transplant	-	-	-	-	2件: 60, 65 💬
487	Stem cell transplantation	-	-	-	-	10件: 13, 19, 20, 46, 65, 90, 125, 164, 234, 326 💬
488	Strimvelis	-	-	-	-	1件: 65 💬
489	Subcuvia	-	-	-	-	3件: 14, 49, 65 💬
490	Subgam	-	-	-	-	1件: 65 💬
491	Sulfadoxine	Sulfadoxine	1件: D00580 💬	-	-	1件: 65 💬
492	Suspension of autologous cd34+cells transduced with the g1xcgd viral vector	-	-	-	-	1件: 65 💬
493	T-cell depleted & cd34+select/w/stemcell enriched product	-	-	-	-	1件: 65 💬
494	Tabelecleucel	-	-	-	-	1件: 65 💬
495	Tablets fexinidazole	Fexinidazole	1件: D11252 💬	-	-	1件: 65 💬
496	Tacrolimus	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	32件:  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
497	Tacrolimus (tacro)	Tacrolimus	2件: D00107, D08556 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 65 💬
498	Tadekinig alfa	Tadekinig alfa	-	-	-	1件: 65 💬
499	Tbx-1400	-	-	-	-	1件: 65 💬
500	Tcr alfa beta t cell depletion	-	-	-	-	1件: 65 💬
501	Thalidomide	Thalidomide	1件: D00754 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	20件:  2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬
502	Therapeutic allogeneic lymphocytes	-	-	-	-	3件: 60, 65, 285 💬
503	There is no recommended inn	-	-	-	-	1件: 65 💬
504	Thiotepa	Thiotepa	1件: D00583 💬	-	-	11件: 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬
505	Thiotepa--escalated dose	Thiotepa	1件: D00583 💬	-	-	4件: 19, 20, 65, 284 💬
506	Thiotepa--single daily dose	Thiotepa	1件: D00583 💬	-	-	4件: 19, 20, 65, 284 💬
507	Thymoglobulin	Antithymocyte immunoglobulin (rabbit)	-	-	-	6件: 36, 51, 60, 65, 96, 326 💬
508	Thymus tissue for transplantation	-	-	-	-	1件: 65 💬
509	Thymus/parathyroid transplantation	-	-	-	-	2件: 65, 235 💬
510	Traditional treatment of cgd and tb	-	-	-	-	1件: 65 💬
511	Transduced lymphocytes	-	-	-	-	1件: 65 💬
512	Transduced patient cd34+ cells	-	-	-	-	1件: 65 💬
513	Transplant conditioning with mobilization and alemtuzumab	Alemtuzumab	1件: D02802 💬	-	-	1件: 65 💬
514	Transplant conditioning with mobilization only	-	-	-	-	1件: 65 💬
515	Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan	Alemtuzumab	5件: D00369, D00583, D01907, D02802, D07966 💬	1件: RRM1 💬	5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism	2件: 65, 164 💬
516	Treosulfan	Treosulfan	1件: D07253 💬	-	-	3件: 13, 19, 65 💬
517	Tyf-il-2rg gene-modified autologous stem cells	-	-	-	-	1件: 65 💬
518	Unrelated bm with t cell depletion	-	-	-	-	1件: 65 💬
519	Unrelated cord blood	-	-	-	-	1件: 65 💬
520	Ustekinumab	Ustekinumab	1件: D09214 💬	3件: IL12A, IL12B, IL23A 💬	26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
521	Valacyclovir	Valaciclovir	3件: D00398, D08664, D10518 💬	-	-	1件: 65 💬
522	Valproic acid	Valproic acid	1件: D00399 💬	7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬	17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism	10件:  3 ,  5 , 26, 34, 65, 89, 90, 222, 256, 331 💬
523	Verorab® (pvrv	-	-	-	-	1件: 65 💬
524	Vigantol	-	-	-	-	4件: 13, 65, 96, 97 💬
525	Vitamin d3	Cholecalciferol	1件: D00188 💬	1件: VDR 💬	4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis	11件:  6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬
526	Vivaglobin	-	-	-	-	2件: 14, 65 💬
527	Vm106	-	-	-	-	1件: 65 💬
528	Water	Water	1件: D00001 💬	-	-	22件:  2 ,  5 ,  6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬
529	X4p-001	-	-	-	-	1件: 65 💬
530	Xifaxan	-	-	-	-	2件: 65, 94 💬
531	Zarzio	-	-	-	-	2件: 65, 285 💬
532	Zoledronate	Zoledronic acid	4件: D01968, D06378, D06379, D08689 💬	1件: FDPS 💬	4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis	2件: 46, 65 💬

先頭へ